CClinicalTrials.gg
CompletedNCT02027285MIAO50Updated Jan 8, 2014

Nutrition, Health and Quality of Life: Development of New Formulations of Traditional Products of the "Made in Italy" Diet Optimized for Consumers With an Age Over 50 Years (MIAO 50)

An interventional study of fortified milk in Aging, sponsored by University of Bologna. Completed at 1 site in Italy. Open to participants aged 63 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2014-01-08.

Sponsored by University of Bologna · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
48
Allocation
Randomized
Ages
63 Years to 80 Years
Sex
All
01

Study summary

The study ""Nutritional trial with fortified milk in 65+ years old subjects" is a part of a complex research project and multi-sectoral development (MIAO 50) with the participation of University Research Institutes and small and medium Italian enterprises.

The general objective of the call is to promote the collaboration between the best scientific knowledge, both epidemiological and experimental, and the most advanced technologies to develop foods with a nutritional profile adequate to the needs of consumers with an age over 50 years old, which are easy to use and make it possible to eat in a healthy manner, complete and balanced and also meets the quality and flavors of traditional Italian.

Read the detailed description

Aging is associated with a functional decline of most physiological systems including the immune system. It could be hypothesized that an inadequate nutritional status may amplify the effects of a low-grade chronic inflammation associated with age influencing the functionality of the immune systems, the resistance to infections, the cognitive function and contributing to an increased morbidity and mortality. Indeed experimental evidence indicate that improving the nutritional status attenuates the decline in immune and cognitive functions, in physical performance associated with age by helping to improve the level of Quality of Life.

Therefore, the present study focus on nutrients and micronutrient which have a role in fighting oxidative stress, in the regulation of inflammatory responses and the immune system.

02

Conditions studied

  • Aging

Keywords

  • fortified milk, aging, health status
03

In context

Lead sponsor

University of Bologna is the lead sponsor of 153 studies on the registry; 24 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
63 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Subjects with an age between 63 and 80 years old, males and females, free-living, resident in Bologna and its province.

Exclusion criteria

Exclusion Criteria:

  • Allergy or intolerance to cow's milk or a dislike. Dietary treatments and use of specific supplements of molecules associated with the proposed intervention up to two months before the start of the trial. Presence of celiac disease and other malabsorption. Presence of disease with poor prognosis in the short term. Chronic therapy with anticoagulants, corticosteroids, and anti-cancer. Exclusion of subjects with onset of chronic-degenerative diseases in the last year, presence of type I diabetes and chronic viral hepatitis.
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Participant, Investigator)
Enrollment
48 participants (actual)

Study arms

  • Experimental
    fortified milk

    The subjects assumed daily 250 ml of fortified milk for 12 weeks. Then, after a period of wash-out of 12-14 weeks they start to assume placebo milk for 12 weeks.

    Dietary Supplement: fortified milk

  • Placebo comparator
    placebo milk

    The subjects assumed daily 250 ml of placebo milk. Then, after a period of wash-out of 12-14 weeks they start to assume fortified milk for 12 weeks.

    Dietary Supplement: fortified milk

Interventions

  • Dietary supplementfortified milk

    "Fortified"Ultra-high temperature (UHT), partly-skimmed milk (1.6% fat), highly digestible (lactose \<0.5%) produced by Granarolo s.p.a. supplemented with long chain unsaturated fatty acids DHA (Docosahexaenoic acid) +EPA (Eicosapentaenoic acid), vitamin D, B12, B6, B9, E,C, Zinc and Selenium versus "placebo" Ultra-high temperature (UHT), partly-skimmed milk (1.6% fat), highly digestible (lactose \<0.5%) of the same manufacturer. The nutrients added are: DHA + EPA 1.4 mg/ml; vitamin D3 0.068 mcg/ml; B6 6.4 mcg/ml; B12 0.01 mcg/ml; B9 (folic acid) 0.80 mcg/ml; vitamin E 0.05 mg/ml; vitamin C 0.19 mg/ml; Zinc 0.04 mg/ml; Selenium 0.22 mcg/ml. The protein content of the milk is 0.04 g/ml.

06

What researchers measure

Primary outcomes

  1. Global health status

    The health status is evaluated by a tests regarding the cognitive function, the functional status, the perceived health status.

    Time frame: Change from baseline global health status at 12 weeks of milk intake

Secondary outcomes

  1. Circulating levels of lipoproteins (Total, HDL and LDL-cholesterol, triglycerides)

    total cholesterol is measured as milligram/100milliliters (mg/100ml); HDL-cholesterol as milligram/100milliliters (mg/100ml); LDL-cholesterol as milligram/100milliliters (mg/100ml); triglycerides as milligram/100milliliters (mg/100ml).

    Time frame: change from baseline total, HDL, and LDL-cholesterol and triglycerides at 12 weeks of milk intake

  2. Levels of blood glucose, creatinine, liver transaminases, homocysteine, folic acid

    Glucose was measured as milligram/deciliter (mg/dl); creatinine as milligram/deciliter (mg/dl), liver transaminases as International units/liter (U/L); homocysteine as micromoles/L and folic acid as nanogram/milliliter (ng/ml)

    Time frame: Change from Baseline levels of glucose, creatinine, liver transaminases, homocysteine and folic acid at 12 weeks of milk intake

  3. Circulating levels of vitamin D, vitamin E, vitamin B6 and vitamin B12

    Vitamin D was measured as nanogram/milliliters (ng/ml); vitamin E as micrograms/milliliters (mcg/ml); vitamin B6 as micrograms/liter (mcg/L) and vitamin B12 as picograms/milliliters (pg/ml)

    Time frame: Change from Baseline levels of vitamin D, vitamin E, vitamin B6 and vitamin B12 at 12 weeks of milk intake

  4. Fatty acid composition of red blood cell membranes as an index of cellular homeostasis

    Time frame: Change from Baseline fatty acid composition of red blood cell membranes at 12 weeks of milk intake

  5. Circulating levels of trace elements such as zinc and selenium

    Zinc and selenium were measured as microgram/liter (mcg/L)

    Time frame: Changes from Baseline levels of zinc and selenium at 12 weeks of milk intake

  6. Oxidation state of cellular proteins

    Time frame: Change from Baseline oxidation state of cellular proteins at 12 weeks of milk intake

  7. Circulating levels of proteins related to inflammatory status such as C reactive protein (CRP); fibrinogen and pro and anti-inflammatory cytokines.

    C reactive protein was measured as milligram/liter (mg/l); fibrinogen as milligram/deciliter (mg/dl); hs-IL6 and hs-IL10 as picograms/milliliter (pg/ml)

    Time frame: Changes from baseline CRP, fibrinogen, high sensitivity interleukin 6 (hs-IL6) and high sensitivity interleukin 10 (hs-IL10)

  8. Blood count and assessment of major lymphocyte sub-populations

    Time frame: Change from Baseline lymphocyte subsets at 12 weeks of milk intake

07

Study locations

1 site
  • University of Bologna-Department of Speciality, Diagnostic and Experimental Medicine
    Bologna, 40126, Italy
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 8, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02027285
Lead sponsor
University of Bologna
Responsible party
Claudio Franceschi (Professor, University of Bologna) — Principal investigator
First posted
Jan 6, 2014
Start date
Feb 2013
Primary completion
Dec 2013
Completion
Dec 2013
Last update
Jan 8, 2014

Study contacts

Claudio Franceschi, MD
study chair · University of Bologna

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion